Authors' response: Comment on "clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma"

Cancer Med. 2022 May;11(9):2038-2039. doi: 10.1002/cam4.4585. Epub 2022 Feb 9.
No abstract available

MeSH terms

  • Adenocarcinoma of Lung* / pathology
  • Adenocarcinoma of Lung* / surgery
  • Adenocarcinoma, Papillary* / pathology
  • Humans
  • Lung Neoplasms* / pathology
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies